Literature DB >> 33901406

The Future of Highly Effective Modulator Therapy in Cystic Fibrosis.

Cori L Daines1, Wayne J Morgan1.   

Abstract

Entities:  

Year:  2021        PMID： 33901406     DOI： 10.1164/rccm.202104-0850ED

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  2 in total

Review 1.  Increasing life expectancy in cystic fibrosis: Advances and challenges.

Authors:  Kimberly A McBennett; Pamela B Davis; Michael W Konstan
Journal:  Pediatr Pulmonol       Date:  2021-11-11

2.  Elexacaftor-Tezacaftor-Ivacaftor as a Final Frontier in the Treatment of Cystic Fibrosis: Definition of the Clinical and Microbiological Implications in a Case-Control Study.

Authors:  Giuseppe Migliorisi; Mirella Collura; Francesca Ficili; Tiziana Pensabene; Dafne Bongiorno; Antonina Collura; Francesca Di Bernardo; Stefania Stefani
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.